These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 15691639

  • 21. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F, Rosati G, De Rosa P, Avallone A, De Rosa V, De Lucia L, Comella P, Comella G.
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer.
    Rao S, Cunningham D, Hawkins RE, Hill ME, Smith D, Daniel F, Ross PJ, Oates J, Norman AR.
    Br J Cancer; 2005 May 09; 92(9):1650-4. PubMed ID: 15856037
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
    Honecker F, Kollmannsberger C, Quietzsch D, Haag C, Schroeder M, Spott C, Hartmann JT, Baronius W, Hempel V, Kanz L, Bokemeyer C.
    Anticancer Drugs; 2002 Jun 09; 13(5):497-503. PubMed ID: 12045461
    [Abstract] [Full Text] [Related]

  • 27. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.
    J Urol; 2007 Jan 09; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [Abstract] [Full Text] [Related]

  • 28. Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.
    Lim JY, Jeung HC, Mun HS, Lee DK, Paik YH, Lee SJ, Yoon DS, Cho JY.
    Anticancer Drugs; 2008 Jul 09; 19(6):631-5. PubMed ID: 18525323
    [Abstract] [Full Text] [Related]

  • 29. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
    Papadimitriou CA, Papakostas P, Karina M, Malettou L, Dimopoulos MA, Pentheroudakis G, Samantas E, Bamias A, Miliaras D, Basdanis G, Xiros N, Klouvas G, Bafaloukos D, Kafiri G, Papaspirou I, Pectasides D, Karanikiotis C, Economopoulos T, Efstratiou I, Korantzis I, Pisanidis N, Makatsoris T, Matsiakou F, Aravantinos G, Kalofonos HP, Fountzilas G.
    BMC Med; 2011 Jan 31; 9():10. PubMed ID: 21281463
    [Abstract] [Full Text] [Related]

  • 30. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C, Lavieille JP, Schmerber S, Cuisnie O, Reyt E.
    Int J Oncol; 2000 Sep 31; 17(3):543-9. PubMed ID: 10938396
    [Abstract] [Full Text] [Related]

  • 31. Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer.
    Shen YC, Li CP, Yen CJ, Hsu C, Lin YL, Lin ZZ, Chen LT, Su WC, Chao Y, Yeh KH, Cheng AL.
    Oncology; 2014 Sep 31; 87(2):104-13. PubMed ID: 25011938
    [Abstract] [Full Text] [Related]

  • 32. Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study.
    Perkhofer L, Berger AW, Beutel AK, Gallmeier E, Angermeier S, Fischer von Weikersthal L, Goetze TO, Muche R, Seufferlein T, Ettrich TJ.
    BMC Cancer; 2019 Oct 23; 19(1):990. PubMed ID: 31646981
    [Abstract] [Full Text] [Related]

  • 33. A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas.
    Caroli-Bosc FX, Van Laethem JL, Michel P, Gay F, Hendlisz A, Forget F, Bleiberg H.
    Eur J Cancer; 2001 Oct 23; 37(15):1828-32. PubMed ID: 11576835
    [Abstract] [Full Text] [Related]

  • 34. Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.
    Hospers GA, Schaapveld M, Nortier JW, Wils J, van Bochove A, de Jong RS, Creemers GJ, Erjavec Z, de Gooyer DJ, Slee PH, Gerrits CJ, Smit JM, Mulder NH.
    Ann Oncol; 2006 Mar 23; 17(3):443-9. PubMed ID: 16500914
    [Abstract] [Full Text] [Related]

  • 35. Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).
    Dahan L, Bonnetain F, Ychou M, Mitry E, Gasmi M, Raoul JL, Cattan S, Phelip JM, Hammel P, Chauffert B, Michel P, Legoux JL, Rougier P, Bedenne L, Seitz JF, Fédération Francophone de Cancérologie Digestive.
    Gut; 2010 Nov 23; 59(11):1527-34. PubMed ID: 20947887
    [Abstract] [Full Text] [Related]

  • 36. 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma.
    Seitz JF, Perrier H, Giovannini M, Capodano G, Bernardini D, Bardou VJ.
    J Chemother; 1998 Jun 23; 10(3):258-65. PubMed ID: 9669654
    [Abstract] [Full Text] [Related]

  • 37. A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.
    Zori Comba A, Blajman C, Richardet E, Bella S, Vilanova M, Cóppola F, Van Kooten M, Rodger J, Giglio R, Balbiani L, Perazzo F, Montiel M, Chacón M, Pujol F, Mickiewicz E, Cazap E, Recondo G, Lastiri F, Simon J, Wasserman E, Schmilovich A.
    Eur J Cancer; 2001 May 23; 37(8):1006-13. PubMed ID: 11334726
    [Abstract] [Full Text] [Related]

  • 38. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
    Di Costanzo F, Bartolucci R, Calabresi F, Sofra M, Marzola M, Belsanti V, Boni C, Bacchi M.
    Ann Oncol; 1992 May 23; 3(5):371-6. PubMed ID: 1616890
    [Abstract] [Full Text] [Related]

  • 39. High-dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
    Di Costanzo F, Gasperoni S, Malacarne P, Belsanti V, Luppi G, Marzola M, Corgna E, Sdrobolini A, Passalacqua R, Figoli F, Algeri R, Zironi S, Angiona S, Boni C.
    Am J Clin Oncol; 1998 Aug 23; 21(4):369-75. PubMed ID: 9708636
    [Abstract] [Full Text] [Related]

  • 40. Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group.
    Schrijvers D, Johnson J, Jiminez U, Gore M, Kosmidis P, Szpirglas H, Robbins K, Oliveira J, Lewensohn R, Schüller J, Riviere A, Arvay C, Langecker P, Jacob H, Cvitkovic E, Vokes E.
    J Clin Oncol; 1998 Mar 23; 16(3):1054-9. PubMed ID: 9508190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.